Hanna Kurlanda-Witek, PhD

Lindau Nobel Laureate Meetings • 27th June 2023

Room for Improvement: The Importance of Diversity and Mentoring in Science

The first session at #LINO23 was a panel discussion on a topic that’s been very popular in the last few years, and still generates plenty of debate: diversity in science. The commitment to diversity is stipulated in Goal 8 of the Lindau Guidelines − support all talent, regardless of its background, in an inclusive, diverse and non-discriminatory manner (lindauguidelines.org/guidelines/).

The panel was made up of four Nobel Laureates: Emmanuelle Charpentier, Martin Chalfie, Christiane Nüsslein-V

Sidekick Health • 14th March 2022

DTx Can Bridge the Healthcare Gap in Rural Areas in the US—DTx Alliance Report Finds

The Digital Therapeutics Alliance (DTA) has published a report on how digital therapeutics (DTx) can help minimize the differences between access to healthcare in rural and urban areas in the United States.

The report referred to data from federal programs, which revealed that nation-wide death rates were higher in rural areas than in urban areas and, in the last decade, the gap in these inequalities has widened for five of the seven major causes of death in the United States—chronic obstructiv

Lindau Nobel • 27th August 2022

Digitalisation – Catching Up with Social Change

Economics is a social science and this was reflected in the many talks and discussions during #LINOecon. How can we better allocate resources for the benefit of society? What role will digitalisation play in the future of work? Should there be stricter rules regarding social media?

For the last several decades, the fact that companies exist only to increase their profit was common knowledge. If the company owners or shareholders were socially-minded, they could use any extra wealth to help soci

Sidekick Health • 11th August 2022

Decentralized Clinical Trials: Technology is the Linchpin

Over the last two years, there has been a striking increase in the number of decentralized clinical trials (DCTs) conducted. This is largely due to advancements in digital health and telehealth spurred by the COVID-19 pandemic. Although the DCT industry is set to expand by 10% annually, there are concerns that transitioning from in-person visits at hospitals or research sites could lead to significant challenges, particularly when integrating new technologies and data workflows.

With this in mi

Lindau Nobel • 1st July 2022

Chemistry Bonding with Medicine

The modern-day fields of medicine and chemistry are fused as never before, which is also evident in Nobel prizes, where doctors often receive the prize in Chemistry and chemists become Laureates of Physiology or Medicine. This year’s Lindau Nobel Laureate Meeting is dedicated to chemistry, but it wouldn’t be complete without the contribution of two Nobel Laureates in Physiology or Medicine and two medical doctors, who are Nobel Laureates in Chemistry. All are actively finding ways to try and cur

Lindau Nobel Mediatheque • 28th June 2022

CV - Sir David MacMillan | Lindau Mediatheque

Sir David W.C. MacMillan shares the 2021 Nobel Prize in Chemistry with Benjamin List for the development of asymmetric organocatalysis. The concept of catalysts – molecules that facilitate chemical reactions – derives from research conducted in the 19th century and rapidly caught on in industrial processes. In his Nobel lecture, David MacMillan pointed out a little-known fact: it was catalysis that sustained the 20th century explosion in world population through the industrial production of ammo

Lindau Nobel Mediatheque • 3rd June 2022

Directed Evolution - Topic | Lindau Mediatheque

Carrots weren’t always orange. The vividly-colored vegetable we know today was developed by gardeners in the Netherlands in the 16th century. A keen observer of Dutch paintings of market stalls and kitchen scenes will notice orange carrots in 16th century paintings and paler, yellow carrots in paintings from before that time [1]. The wild mustard plant is a weed-like plant with long stems and small yellow flowers. Over the course of centuries, farmers cultivated different vegetables from the mus

Sidekick Health • 11th April 2022

Should Pharma Consider Software as a Medical Device (SaMD)?

According to Insider Intelligence, the digital therapeutics (DTx) market is forecast to be a $56 billion global industry by 2025. Much of this dynamic growth will be spurred by software, most of which will be software as a medical device (SaMD).

SaMD are software functions that help prevent, manage, or treat medical conditions, without being part of medical device hardware−in other words, the software works independently from another device. If the software is a feature of the hardware and help

Lindau Nobel Mediatheque • 18th November 2022

Climate Economics - Topic | Lindau Mediatheque

In 1987, the World Commission on Environment and Development published, “Our Common Future”, a report widely known today as the Brundtland Report, named after the Commission’s chairwoman. The report featured a definition of sustainability; “meeting the needs of the present without compromising on the ability of future generations to meet their own needs.”1 In other words, how can we achieve growth, but use resources responsibly enough to make them last for the future? Economic activity affects t